Cart
sales@molnova.com
N6-Methyladenine
CAS No. 443-72-1
N6-Methyladenine( 6-(Methylamino)Purine )
Catalog No. M28073 CAS No. 443-72-1
N6-Methyladenine is a modified purine commonly found in genomes of prokaryotes, protists, and plants. N6-methyladenine affects diverse DNA functions, including replication, repair, and expression.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 45 | In Stock |
|
| 10MG | 63 | In Stock |
|
| 25MG | 103 | In Stock |
|
| 50MG | 150 | In Stock |
|
| 100MG | 223 | In Stock |
|
| 500MG | 482 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameN6-Methyladenine
-
NoteResearch use only, not for human use.
-
Brief DescriptionN6-Methyladenine is a modified purine commonly found in genomes of prokaryotes, protists, and plants. N6-methyladenine affects diverse DNA functions, including replication, repair, and expression.
-
DescriptionN6-Methyladenine is a modified purine commonly found in genomes of prokaryotes, protists, and plants. N6-methyladenine affects diverse DNA functions, including replication, repair, and expression.
-
In Vitro——
-
In Vivo——
-
Synonyms6-(Methylamino)Purine
-
PathwayCell Cycle/DNA Damage
-
TargetNucleoside Antimetabolite/Analog
-
RecptorTAK1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number443-72-1
-
Formula Weight149.157
-
Molecular FormulaC6H7N5
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCNc1[nH]cnc2ncnc12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Emily Derbyshire, et al. Novel inhibitors of transforming growth factor kinase and methods of use thereof. Patent US20180105500A1.
molnova catalog
related products
-
Raltitrexed
A quinazoline antifolate thymidylate synthase (TS) inhibitor with Ki of 62 nM.
-
GS-441524
GS-441524 was shown to be a safe and effective treatment for feline infectious peritonitis (FIP). The optimum dosage was found to be 4.0 mg/kg SC q24h for at least 12 weeks.
-
Acelarin
A gemcitabine phosphoramidate prodrug that can overcome the key cancer resistance.
